Population pharmacokinetic analyses of methotrexate in pediatric patients: a systematic review
European Journal of Clinical Pharmacology · 2024
DOI: 10.1007/s00228-024-03665-x ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Journal of Clinical Pharmacology, 2024. Verfasst von Yu Cheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Shengjing Hospital Affiliated to China Medical University, 36 Sanhao Street, Shenyang, 110004, Liaoning Province, China. Hauptthemen laut MEDLINE: Methotrexate, Models, Biological, Antimetabolites, Antineoplastic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Science Fund for Distinguished Young Scholars of Fujian Province, Joint Funds for the Innovation of Science and Technology of Fujian Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND AND OBJECTIVES: Methotrexate is widely utilized in the chemotherapy of malignant tumors and autoimmune diseases in the pediatric population, but dosing can be challenging. Several population pharmacokinetic models were developed to characterize factors influencing variability and improve individualization of dosing regimens. However, significant covariates included varied across studies. The primary objective of this review was to summarize and discuss population pharmacokinetic models of methotrexate and covariates that influence pharmacokinetic variability in pediatric patients. METHODS: Systematic searches were conducted in the PubMed and EMBASE databases from inception to 7 July 2023. Reporting Quality was evaluated based on a checklist with 31 items. The characteristics of studies and information for model construction and validation were extracted, summarized, and discussed. RESULTS: Eighteen studies (four prospective studies and fourteen retrospective studies with sample sizes of 14 to 772 patients and 2.7 to 93.1 samples per patient) were included in this study. Two-compartment models were the commonly used structural models for methotrexate, and the clearance range of methotrexate ranged from 2.32 to 19.03 L/h (median: 6.86 L/h). Body size and renal function were found to significantly affect the clearance of methotrexate for pediatric patients. There were limited reports on the role of other covariates, such as gene polymorphisms and co-medications, in the pharmacokinetic parameters of methotrexate pediatric patients. Internal and external evaluations were used to assess the performance of the population pharmacokinetic models. CONCLUSION: A more rigorous external evaluation needs to be performed before routine clinical use to select the appropriate PopPK model. Further research is necessary to incorporate larger cohorts or pool analyses in specific susceptible pediatric populations to improve the understanding of predicted exposure profiles and covariate identification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Shengjing Hospital Affiliated to China Medical University, 36 Sanhao Street, Shenyang, 110004, Liaoning Province, China.
- Department of Pharmacy, Fujian Medical University Union Hospital, 29 Xin Quan Rd, Gulou, Fuzhou, 350001, Fujian Province, People's Republic of China.
- Department of Pharmacy, Fujian Medical University Union Hospital, 29 Xin Quan Rd, Gulou, Fuzhou, 350001, Fujian Province, People's Republic of China. liumb0591@fjmu.edu.cn.
- Department of Pharmacy, Shengjing Hospital Affiliated to China Medical University, 36 Sanhao Street, Shenyang, 110004, Liaoning Province, China. mlzhao@cmu.edu.cn.
Förderung
- Science Fund for Distinguished Young Scholars of Fujian Province
- Joint Funds for the Innovation of Science and Technology of Fujian Province
- National Natural Science Foundation of China
- Outstanding Scientific Fund of Shengjing Hospital
Zitieren
APA
Cheng, Y., Zhang, Y., Zhang, Y., Liu, M., & Zhao, L. (2024). Population pharmacokinetic analyses of methotrexate in pediatric patients: a systematic review. European Journal of Clinical Pharmacology. https://doi.org/10.1007/s00228-024-03665-x
Vancouver
Cheng Y, Zhang Y, Zhang Y, Liu M, Zhao L. Population pharmacokinetic analyses of methotrexate in pediatric patients: a systematic review. European Journal of Clinical Pharmacology. 2024. doi:10.1007/s00228-024-03665-x
BibTeX
@article{Cheng2024,
author = {Cheng, Yu and Zhang, Yujia and Zhang, Ying and Liu, Maobai and Zhao, Limei},
title = {Population pharmacokinetic analyses of methotrexate in pediatric patients: a systematic review},
journal = {European Journal of Clinical Pharmacology},
year = {2024},
doi = {10.1007/s00228-024-03665-x}
}
EUVIMED